Allogene Therapeutics Inc (ALLO)
2.09
+0.14
(+7.18%)
USD |
NASDAQ |
Dec 24, 16:00
Allogene Therapeutics Shareholders Equity (Quarterly): 463.75M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | 430.80M |
| AIM ImmunoTech Inc | 2.912M |
| Perspective Therapeutics Inc | 328.47M |
| Protalix BioTherapeutics Inc | 32.44M |
| Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 589.12M |
| Total Liabilities (Quarterly) | 125.37M |